- Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium
-
Phan NT, Tran QT, Nguyen NP, Nguyen HT, Tran LD, Pham VC, Bennett K, Chávez-Blanco A, Plante M, Lecuru FR, Suh DH, Nout R, Tan DS
- KMID: 2552666
- J Gynecol Oncol.
- 2023 Nov;34(6):e89.
- doi: 10.3802/jgo.2023.34.e89
-
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis
-
Kim Y, Kang GH, Kim H
- KMID: 2552660
- J Gynecol Oncol.
- 2023 Nov;34(6):e73.
- doi: 10.3802/jgo.2023.34.e73
Objective The aim of this study is to determine the histologic presence of heterologous component as a prognostic factor in gynecologic carcinosarcoma through a systematic review and meta-analysis. Methods PubMed, Web of Science,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis
-
Kanno M, Yunokawa M, Kurihara N, Aoki Y, Omi M, Tanigawa T, Kanao H
- KMID: 2552654
- J Gynecol Oncol.
- 2023 Nov;34(6):e77.
- doi: 10.3802/jgo.2023.34.e77
Objective The efficacy of intra-abdominal cytoreductive surgery in patients with endometrial cancer and distant metastasis is equivocal. We investigated the effectiveness of such surgical treatment and whether it should be performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis
-
Yi J, Wu M, Zheng Z, Zhou Q, Li X, Lu Y, Liu P
- KMID: 2552657
- J Gynecol Oncol.
- 2023 Nov;34(6):e71.
- doi: 10.3802/jgo.2023.34.e71
Objective More than 75% of ovarian cancer patients are diagnosed at advanced stages and die of tumor cell metastasis. This study aimed to identify new epigenetic and transcriptomic alterations associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
-
Nicolai L, Yigit R, Bleeker MC, Bart J, Velden Jvd, Mom CH
- KMID: 2552661
- J Gynecol Oncol.
- 2023 Nov;34(6):e75.
- doi: 10.3802/jgo.2023.34.e75
Objective In the 2018 FIGO staging system, cervical cancers with ≤5 mm depth of invasion (DOI) and a diameter of >7 mm, first classified as stage IB, are classified as stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival
-
Coada CA, Dondi G, Ravegnini G, Costanzo SD, Tesei M, Fiuzzi E, Stanislao MD, Giunchi S, Zamagni C, Bovicelli A, Hrelia P, Angelini S, Iaco PD, Perrone AM
- KMID: 2552659
- J Gynecol Oncol.
- 2023 Nov;34(6):e82.
- doi: 10.3802/jgo.2023.34.e82
Objective Neoadjuvant chemotherapy (NACT) represents a treatment option in patients with advanced epithelial ovarian cancer (AEOC) who are not good candidates for primary debulking surgery. Usually, 3 cycles of chemotherapy before... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R)
-
Yoo JG, Kim JH, Park EY, Kim I, Lim MC, Lee SJ
- KMID: 2552658
- J Gynecol Oncol.
- 2023 Nov;34(6):e72.
- doi: 10.3802/jgo.2023.34.e72
Objective We aimed to evaluate the long-term efficacy of consolidation hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with primary epithelial ovarian cancer. Methods This retrospective cohort study included patients who underwent second-look surgery either... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiologic characteristics and a prognostic nomogram for patients with vulvar cancer: results from the Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1975 to 2016
-
Wei S, Li L, Yi T, Su L, Gao Q, Wu L, OuYang Z
- KMID: 2552665
- J Gynecol Oncol.
- 2023 Nov;34(6):e81.
- doi: 10.3802/jgo.2023.34.e81
Objective To elucidate clinical characteristics and build a prognostic nomogram for patients with vulvar cancer. Methods The study population was drawn from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer
-
Togami S, Fukuda M, Mizuno M, Yanazume S, Kobayashi H
- KMID: 2552652
- J Gynecol Oncol.
- 2023 Nov;34(6):e68.
- doi: 10.3802/jgo.2023.34.e68
Objective This study aimed to validate the surgical and oncologic outcomes of robotic surgery with sentinel node navigation surgery (SNNS) in endometrial cancer. Methods This study included 130 patients with endometrial cancer, who... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes and prognostic factors of surgically treated extramammary Paget’s disease of the vulva
-
Cho A, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Park JY
- KMID: 2552664
- J Gynecol Oncol.
- 2023 Nov;34(6):e76.
- doi: 10.3802/jgo.2023.34.e76
Objective Extramammary Paget’s disease (EMPD) of the vulva is a rare disease which predominantly presents in postmenopausal Caucasian women. As yet, no studies on Asian female patients with EMPD have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
-
Li X, Yang X, Cheng Y, Dong Y, Wang J, Wang J
- KMID: 2552653
- J Gynecol Oncol.
- 2023 Nov;34(6):e69.
- doi: 10.3802/jgo.2023.34.e69
Objective Metabolic syndrome (MetS) is closely related to the increased risk and poor prognosis of endometrial cancer (EC). The purpose of this study was to analyze the relationship between metabolic risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Pneumovaginoscopy-assisted radical hysterectomy for early-stage cervical cancer: a novel bidirectional approach for tumor spillage prevention and R0 resection
-
Kita M, Butsuhara Y, Hisamatsu Y, Yokoe T, Okada H
- KMID: 2552663
- J Gynecol Oncol.
- 2023 Nov;34(6):e80.
- doi: 10.3802/jgo.2023.34.e80
Objective This study evaluated the feasibility and outcomes of pneumovaginoscopy-assisted radical hysterectomy (PVRH) for cervical cancer up to stage IIA using a bidirectional fascia-oriented and nerve-sparing surgical approach. Methods This retrospective observational cohort... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis
-
Lee D, Kim YN, Cho SH, Yoon Hs, Kim YT, Kim S, Kim SW
- KMID: 2552655
- J Gynecol Oncol.
- 2023 Nov;34(6):e79.
- doi: 10.3802/jgo.2023.34.e79
Objective We aimed to investigate the oncologic outcomes of patients with endometrial cancer who underwent sentinel lymph node (SLN) biopsy without ultrastaging compared with that of those who underwent lymphadenectomy (LND). Methods Patients... -
- CITED
-
- Close
- SHARE
-
- Close
- The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study
-
Zhou X, Liang D, Li Q, Zhao L, Bin Y, Ma F, Wu R, Lv Y, Li Q
- KMID: 2552662
- J Gynecol Oncol.
- 2023 Nov;34(6):e78.
- doi: 10.3802/jgo.2023.34.e78
Objective Traditional uterine manipulator is considered as the main reason for short survival of patients with early-stage cervical cancer during minimally invasive surgery. This study aims to assess the sealing effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience
-
Kim YN, Chung YS, Lee JH, Park E, Lee ST, Kim S, Lee JY
- KMID: 2552656
- J Gynecol Oncol.
- 2023 Nov;34(6):e70.
- doi: 10.3802/jgo.2023.34.e70
Objective To evaluate the landscape of gene alterations and immunohistochemistry (IHC) profiles of patients with ovarian cancer for targeted therapy and investigate the real-world experience of applying precision medicine. Methods Patients diagnosed with... -
- CITED
-
- Close
- SHARE
-
- Close
